triazoles has been researched along with enalapril in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishidoya, S; Klahr, S; Morrissey, J | 1 |
| Ishidoya, S; Klahr, S; McCracken, R; Morrissey, J; Reyes, A | 1 |
| Blaine, EH; Huang, HC; Koepke, JP; Manning, RE; Olins, GM; Reitz, DB; Smits, GJ | 1 |
| Blaine, EH; Blehm, DJ; Frierdich, GE; McMahon, EG; Schuh, JR | 1 |
| Klahr, S; Morrissey, JJ | 1 |
| Araújo, CV; Figueiredo, MR; Kaplan, MA; Lessa, MA; Pimenta, D; Tibiriçá, E | 1 |
| Jackson, EK | 1 |
| Brown, NJ; Byrne, L; Kunchakarra, S; Marney, A | 1 |
| He, L; Lee, J; Mendell-Harary, J; Tao, B; Walker, J; Wickremasingha, P; Wight, D | 1 |
1 review(s) available for triazoles and enalapril
| Article | Year |
|---|---|
Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Collagen; Enalapril; Extracellular Matrix Proteins; Fibrosis; Kidney; Kidney Diseases; Kidney Tubules; Macrophages; Monocytes; Rats; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Triazoles; Ureteral Obstruction | 1995 |
1 trial(s) available for triazoles and enalapril
| Article | Year |
|---|---|
Interactive hemodynamic effects of dipeptidyl peptidase-IV inhibition and angiotensin-converting enzyme inhibition in humans.
Topics: Adult; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Enalapril; Female; Heart Rate; Hemodynamics; Humans; Insulin; Male; Metabolic Syndrome; Middle Aged; Peptidyl-Dipeptidase A; Prospective Studies; Pyrazines; Renal Circulation; Sitagliptin Phosphate; Sodium; Triazoles | 2010 |
7 other study(ies) available for triazoles and enalapril
| Article | Year |
|---|---|
Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction.
Topics: Actins; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Collagen; Disease Models, Animal; Enalapril; Female; Immunohistochemistry; Monocytes; Nephritis, Interstitial; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Triazoles; Ureteral Obstruction | 1995 |
In vivo pharmacology of SC-51316, a nonpeptidic angiotensin II receptor antagonist.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Depression, Chemical; Dogs; Dose-Response Relationship, Drug; Enalapril; Hypertension; Imidazoles; Losartan; Male; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Tetrazoles; Triazoles | 1993 |
Differential effects of renin-angiotensin system blockade on atherogenesis in cholesterol-fed rabbits.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Feed; Animals; Arteriosclerosis; Cholesterol, Dietary; Disease Models, Animal; Dose-Response Relationship, Drug; Enalapril; Male; Rabbits; Renin-Angiotensin System; Tetrazoles; Time Factors; Triazoles | 1993 |
Differential effects of ACE and AT1 receptor inhibition on chemoattractant and adhesion molecule synthesis.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Adhesion; Cell Adhesion Molecules; Chemokine CCL2; Enalapril; Female; Gene Expression Regulation; Immunohistochemistry; Intercellular Adhesion Molecule-1; Macrophages; Monocytes; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Tetrazoles; Triazoles; Ureteral Obstruction; Vascular Cell Adhesion Molecule-1 | 1998 |
Antihypertensive effects of crude extracts from leaves of Echinodorus grandiflorus.
Topics: Adrenergic beta-Antagonists; Alismataceae; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Atenolol; Azepines; Blood Pressure; Bradykinin; Brazil; Cyclooxygenase Inhibitors; Enalapril; Hemodynamics; Indomethacin; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phytotherapy; Plant Extracts; Plant Leaves; Platelet Membrane Glycoproteins; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, G-Protein-Coupled; Triazoles | 2008 |
Dipeptidyl peptidase IV inhibition alters the hemodynamic response to angiotensin-converting enzyme inhibition in humans with the metabolic syndrome.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Drug Therapy, Combination; Enalapril; Heart Rate; Hemodynamics; Humans; Metabolic Syndrome; Models, Biological; Peptidyl-Dipeptidase A; Pyrazines; Sitagliptin Phosphate; Triazoles | 2010 |
Lack of effect of colesevelam HCl on the single-dose pharmacokinetics of aspirin, atenolol, enalapril, phenytoin, rosiglitazone, and sitagliptin.
Topics: Adolescent; Adult; Allylamine; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Anticonvulsants; Antihypertensive Agents; Area Under Curve; Aspirin; Atenolol; Colesevelam Hydrochloride; Dose-Response Relationship, Drug; Drug Interactions; Enalapril; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Phenytoin; Pyrazines; Rosiglitazone; Sitagliptin Phosphate; Thiazolidinediones; Tissue Distribution; Triazoles; Young Adult | 2014 |